Pain News and Research

Latest Pain News and Research

Women recover faster from knee replacement surgery than men

Although women generally have worse knee function and more severe symptoms before undergoing surgery for knee replacement than men, they recover faster after the operation. Men take longer to recover but, after a year, they catch up with women and there are no differences in surgery outcomes at that time.

30 Jun 2011

Protect your ears from loud noise of fireworks, trains, and concerts

The sounds of summer can be noisy. "Fireworks, trains, concerts and road construction can be harmful to your hearing. And once hearing is damaged, it cannot be repaired," said Jyoti Bhayani, certified audiologist at Gottlieb Memorial Hospital, part of Loyola University Health System.

30 Jun 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, under which Cipher has granted Vertical the exclusive right to market, sell and distribute CIP-TRAMADOL ER in the United States.

29 Jun 2011

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).

29 Jun 2011

Two-pronged 'hybrid' procedure for treatment of atrial fibrillation

Doctors at Washington University School of Medicine in St. Louis are performing a new procedure to treat atrial fibrillation, a common irregular heartbeat.

29 Jun 2011

Hi-Tech Pharmacal pays $3.6M for rights to Atley's branded pain treatment products

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that they acquired marketing and distribution rights to several unique branded products for the treatment of pain from Atley Pharmaceuticals. Some products are approved and some are pending approval with the Food and Drug Administration (FDA).

29 Jun 2011

Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEA, also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration (wet AMD).

29 Jun 2011

Cotton swab dramatically reduces infections in post-operative incision sites

A simple item found in almost every medicine cabinet - a cotton swab -- may be a key tool in the fight against post-surgical wound infections.

29 Jun 2011

Glybera gene therapy reduces pancreatitis risk in Lipoprotein Lipase Deficiency patients

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today released data showing that its gene therapy Glybera® (alipogene tiparvovec) significantly reduces the risk of pancreatitis in patients with Lipoprotein Lipase Deficiency (LPLD). Pancreatitis, or inflammation of the pancreas, is a major clinical symptom of LPLD.

29 Jun 2011

Physical activity can positively affect cells in intervertebral discs

Physical exercise has a positive effect on the formation of cells in the intervertebral discs. This is shown by a study from the Sahlgrenska Academy, University of Gothenburg, presented at the annual meeting of the International Society for the Study of the Lumbar Spine (ISSLS), which is currently taking place in Gothenburg.

29 Jun 2011

Genetic tools that enable cell type-specific delivery hold promise for combating incurable neurologic diseases

Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Five of the most exciting developments in this rapidly advancing field are presented in a series of articles in the June issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc..

29 Jun 2011

FDA clears Nuvo's IND for Lidocaine Spray formulation

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.

29 Jun 2011

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

Bio-Nucleonics' lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron®, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer.

28 Jun 2011

NUROMOL non-prescription painkiller now available in pharmacies across the UK

A new non-prescription painkiller is now available in pharmacies across the UK, heralding the first UK painkiller combination of ibuprofen and paracetamol in 'over-the-counter' pain relief.

28 Jun 2011

Body sculpting technique eliminates abdominal fat with few side effects

A "body sculpting" technique using high-intensity focused ultrasound to eliminate unwanted abdominal fat effectively reduces waist circumference, with only minor pain and side effects, reports a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Jun 2011

Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer

Amgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.

28 Jun 2011

New software program can allow scientists to produce single brain images

A University of Colorado Boulder research team has developed a new software program allowing neuroscientists to produce single brain images pulled from hundreds of individual studies, trimming weeks and even months from what can be a tedious, time-consuming research process.

28 Jun 2011

Black church members report better quality of life than general population

Health disparities between black Americans and the rest of the nation have been well-documented in medical journals. But one study shows that blacks who identify as members of the Seventh-day Adventist Church actually report a better quality of life than the average American.

28 Jun 2011

Health law headlines: PR challenges and overhaul tell-alls

Although Democrats are having some success with attacks on the GOP Medicare plan, they are still playing defense on the health law, according to Politico. Meanwhile, former Office of Management and Budget Director Peter Orszag writes a "tell-all" for the magazine Foreign Affairs about the health overhaul.

28 Jun 2011

Roll over Hippocrates: Medicine undergoing revolution of overturning traditional ethics

Everybody seems to think that doctors swear to the Oath of Hippocrates, and follow a long ethical tradition dating back to the 5th century before Christ. Not anymore. The new doctors seem to be making it up as they go along.

27 Jun 2011

Pain News and Research

Latest Pain News and Research

Women recover faster from knee replacement surgery than men

Protect your ears from loud noise of fireworks, trains, and concerts

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Two-pronged 'hybrid' procedure for treatment of atrial fibrillation

Hi-Tech Pharmacal pays $3.6M for rights to Atley's branded pain treatment products

Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD

Cotton swab dramatically reduces infections in post-operative incision sites

Glybera gene therapy reduces pancreatitis risk in Lipoprotein Lipase Deficiency patients

Physical activity can positively affect cells in intervertebral discs

Genetic tools that enable cell type-specific delivery hold promise for combating incurable neurologic diseases

FDA clears Nuvo's IND for Lidocaine Spray formulation

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

NUROMOL non-prescription painkiller now available in pharmacies across the UK

Body sculpting technique eliminates abdominal fat with few side effects

Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer

New software program can allow scientists to produce single brain images

Black church members report better quality of life than general population

Health law headlines: PR challenges and overhaul tell-alls

Roll over Hippocrates: Medicine undergoing revolution of overturning traditional ethics

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Pain News and Research

Latest Pain News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in